Planetpharma SA Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Planetpharma SA Pharmaceutical Import Records from India — 2 Products, $1.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Planetpharma SA — Pharmaceutical Importer Profile (2026) | 2 Products, $1.5M Trade | TransData Nexus

Planetpharma SA

Pharmaceutical Importer · France · Advanced Antibiotics Focus · $1.5M Total Trade · DGFT Verified

Planetpharma SA is a pharmaceutical importer based in France with a total trade value of $1.5M across 2 products in 1 therapeutic categories. Based on 39 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Planetpharma SA sources from 9 verified Indian suppliers, with Amanys Pharma India Private Limited accounting for 44.0% of imports.

Planetpharma SA — Import Portfolio & Supplier Network

Planetpharma SA import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Planetpharma SA?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Amanys Pharma India Private Limited	$2.5M	161	44.0%
Ajanta Pharma Limited	$1.1M	71	20.0%
Naari Pharma Private Limited	$1.1M	54	19.7%

What Formulations Does Planetpharma SA Import?

Formulation	Value	Ships
Cefixime sp 200 cefixime 200mgtabs	$150.0K	3
Fixim oral suspension 60 ML [cefexime	$150.0K	3
Cefixime sp 200 cefixime 200mgtabs packof 1x10tabs ) item code:cefi121 3000000220702 batch no:setb23009,setb23009	$140.0K	3
Vildaril m TAB 50/1000MG[7700 x 3 x 10	$129.8K	3
Albendazole sp 400 (albendazole 400MG	$122.7K	4
Cefixime sp 200 (cefixime 200 MG tabs Pack of 1x10 tabs) item code:cefi121 3000000220702 batch no: setb24010	$100.0K	2
Cefixime sp 200 (cefixime 200 MG tabs Pack of 1x10 tabs) item code:cefi121 3000000220702 batch no: setb24011	$100.0K	2
Pharmaceutical products- postpill	$97.2K	4
Paraven sp (paracetamol intravenous	$97.0K	2
Cefixime sp 100 (cefixime for oral suspension USP 100MG/5ML) item code:cefi124 3990000000 batch no:scsb24004	$89.2K	2
Rosutor TAB 20MG[rosuvastatin tablets	$86.1K	2
Ceftriaxone sp 1000 (ceftriaxone for	$83.1K	2
Ceftriaxone sp 1000 (ceftriaxone for injection USP 1g with 10 ML wfi) item code:ceft280 3000000220825 batch	$73.2K	4
Celecoxib sp 200 (celecoxib 200 MG capsule ) capsule item code:cele151 3990000001299 batch no: 6eoo12401 mfg:dec-24	$56.7K	2
Cefuroxime sp 500(cefuroxime 500 MG tabspack of 1 x 10 tabs) item code:cefu1493000000220948 batch: sftb24002 mfg	$55.8K	2

Planetpharma SA imports 256 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Cefixime	Advanced Antibiotics	$1.3M	27	0.8%	16
2	Ceftazidime	Advanced Antibiotics	$129.0K	12	1.2%	8

Planetpharma SA imports 2 pharmaceutical products across 1 categories into France totaling $1.5M.

Planetpharma SA — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Planetpharma SA, established in 1992, is a French subsidiary of the UbiPharm group, specializing in the import and export of pharmaceutical products. Headquartered in Le Grand-Quevilly, Normandy, France, the company operates as both a wholesale distributor and a pharmaceutical depot. It serves as a crucial intermediary between pharmaceutical laboratories and their customers, particularly in Africa and France's overseas territories.

The company manages the distribution of medications for over 100 pharmaceutical laboratories to 150 wholesaler-distributor customers across 23 African countries. Planetpharma SA's role in France's pharmaceutical distribution network is multifaceted, encompassing storage, order preparation, traceability, and shipping of goods. This comprehensive approach ensures a continuous supply of health products to pharmaceutical and medical institutions, thereby maintaining the integrity of the medicine distribution chain and mitigating the risk of disruptions.

2Distribution Network

Planetpharma SA operates two storage platforms in France, covering a total area of 25,000 m² with a storage capacity of 37,000 pallets. These facilities are equipped with automated systems that facilitate rapid storage and order preparation, all in compliance with good distribution practices. The strategic location near the ports of Rouen and Le Havre enhances the company's logistics capabilities, enabling efficient distribution to various regions.

The company's distribution network extends beyond France, reaching 23 African countries and three overseas territories. This extensive coverage underscores Planetpharma SA's significant role in ensuring the availability of pharmaceutical products across diverse markets.

3Industry Role

In France's pharmaceutical supply chain, Planetpharma SA functions as a wholesale distributor and pharmaceutical depot. It imports pharmaceutical products from various countries, including India, and manages their storage, order preparation, and distribution. By handling these operations internally, the company ensures compliance with good distribution practices and maintains the integrity of the supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Planetpharma SA

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Planetpharma SA's sourcing strategy exhibits a high degree of concentration, with its top five products—Cefixime, Ceftazidime, and others—accounting for 100% of its imports from India. This indicates a focused procurement approach, potentially leveraging volume discounts and streamlined logistics. However, such concentration may pose risks related to supply chain disruptions or changes in supplier dynamics. The company's reliance on a limited number of suppliers for these products suggests a strategic choice aimed at optimizing operational efficiency.

2Supply Chain Resilience

Planetpharma SA's supply chain resilience is bolstered by its partnerships with multiple Indian suppliers, including AMANYS PHARMA INDIA PRIVATE LIMITED, AJANTA PHARMA LIMITED, and others. This diversified supplier base mitigates risks associated with single-source dependency. The company's adoption of automated systems in its warehouses enhances operational efficiency and responsiveness to supply chain fluctuations. Additionally, Planetpharma SA's compliance with good distribution practices and its status as an Authorized Economic Operator (AEO) reflect a commitment to regulatory compliance and supply chain security.

3Strategic Implications

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports is the Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM). The ANSM is responsible for ensuring the safety, efficacy, and quality of health products available in the French market. Key legislation governing pharmaceutical imports includes the Public Health Code, which outlines the requirements for marketing authorizations, importation procedures, and distribution practices. The marketing authorization pathway for Indian generics involves obtaining approval from the ANSM, which assesses the bioequivalence, quality, and safety of the generic product compared to the reference medicine.

2Import Licensing & GMP

Import licensing requirements in France stipulate that pharmaceutical products must be authorized by the ANSM before being imported and distributed. Manufacturers and importers must provide evidence of Good Manufacturing Practice (GMP) compliance, which can be demonstrated through certifications such as EU GMP, WHO GMP, or PIC/S. These certifications ensure that the manufacturing processes meet international standards for quality and safety. Additionally, wholesale distribution authorization is required to legally distribute pharmaceutical products within France.

Quality & Labeling

Planetpharma SA — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Planetpharma SA's focus on advanced antibiotics, particularly Cefixime and Ceftazidime, aligns with the growing demand for effective treatments against bacterial infections. The importation of these products is driven by the need to address antibiotic resistance and provide healthcare professionals with reliable therapeutic options. By concentrating on this therapeutic area, Planetpharma SA positions itself as a key supplier of critical medications in the French and African markets.

2Sourcing Profile

Planetpharma SA's sourcing strategy emphasizes the procurement of generic drugs, with a preference for formulations that offer cost-effective alternatives to branded medications. India's robust pharmaceutical manufacturing sector, known for its compliance with international GMP standards, makes it a strategic partner for Planetpharma SA. This collaboration enables the company to offer a diverse range of high-quality pharmaceutical products to its customers.

3Market Positioning

Based on its product mix, Planetpharma SA serves multiple segments of the French pharmaceutical market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. Its focus on advanced antibiotics positions the company as a critical supplier of essential medicines, catering to the needs of various healthcare providers and institutions.

Seller's Guide — How to Become a Supplier to Planetpharma SA

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Planetpharma SA, particularly in the supply of advanced antibiotics and other high-demand pharmaceutical products. Gaps in Planetpharma SA's current sourcing may include the need for additional suppliers to diversify its product offerings and mitigate potential supply chain risks. Indian exporters can leverage this opportunity by ensuring compliance with French regulatory standards and demonstrating the quality and reliability of their products.

2Requirements & Qualifications

Indian exporters seeking to supply Planetpharma SA and the French market must obtain GMP certifications recognized by the ANSM, such as EU GMP, WHO GMP, or PIC/S. Additionally, they must ensure that their products meet French labeling requirements, including French language labeling and serialization mandates. Compliance with these standards is essential for successful market entry and distribution in France.

3How to Approach

Frequently Asked Questions — Planetpharma SA

What products does Planetpharma SA import from India?

Planetpharma SA imports 2 pharmaceutical products across 1 categories. Top imports: Cefixime ($1.3M), Ceftazidime ($129.0K).

Who supplies pharmaceuticals to Planetpharma SA from India?

Planetpharma SA sources from 9 verified Indian suppliers. The primary supplier is Amanys Pharma India Private Limited (44.0% of imports, $2.5M).

What is Planetpharma SA's total pharmaceutical import value?

Planetpharma SA's total pharmaceutical import value from India is $1.5M, based on 39 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Planetpharma SA focus on?

Planetpharma SA imports across 1 categories. The largest: Advanced Antibiotics (100.0%).

Get Full Planetpharma SA Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.